Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Operating income | -$29.4K | -$666K | -$2.58M | -$5.35M | -$7.34M | -$14.9M | -$13.9M | -$17.5M | -$19.0M | -$27.6M |
| Net income | -$29.3K | -$659K | -$2.54M | -$5.32M | -$7.38M | -$18.6M | -$13.9M | -$17.5M | -$18.8M | -$28.2M |
| EPS (diluted) | -$0.00 | -$0.05 | -$0.15 | -$0.30 | -$0.40 | -$2.74 | -$1.15 | -$0.78 | -$15.26 | -$12.36 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$21.1K | -$791K | -$1.81M | -$4.09M | -$5.91M | -$10.3M | -$11.0M | -$14.0M | -$15.7M | -$23.8M |
| Capital expenditures | $0.00 | $15.1K | $77.1K | $261K | $110K | $54.8K | $1.64M | $1.70M | $2.49M | $3.93M |
| Free cash flow | -$21.1K | -$806K | -$1.89M | -$4.36M | -$6.02M | -$10.3M | -$12.6M | -$15.7M | -$18.2M | -$27.7M |
| Share buybacks | $188K | $0.00 | — | — | — | — | — | — | — | — |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $392K | $4.30M | $6.55M | $3.12M | $1.47M | $9.08M | $3.80M | $9.23M | $13.1M | $6.94M |
| Total assets | $392K | $4.33M | $6.65M | $3.86M | $2.25M | $9.85M | $7.25M | $13.8M | $18.7M | $14.8M |
| Total liabilities | $29.7K | $15.5K | $179K | $980K | $3.52M | $1.01M | $2.17M | $2.27M | $1.66M | $1.87M |
| Shareholders' equity | $363K | $4.32M | $6.47M | $2.88M | -$1.28M | $8.84M | $5.08M | $11.5M | $17.1M | $13.0M |
| Retained earnings | -$49.4K | -$709K | -$3.25M | -$8.57M | -$15.9M | -$34.6M | -$48.5M | -$65.9M | -$84.8M | -$113M |
| Shares (wtd avg diluted) | 9.73M | 13.3M | 16.6M | 17.9M | 6.30M | 6.81M | 12.1M | 22.4M | 1.23M | 2.29M |
Every figure is extracted from Modular Medical, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.